Back to search
FDAFDA · Food and drugs·Recall number D-0499-2020

Magnesia Phosphorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64197 2.

Published November 27, 2019 · Recall initiated: November 8, 2019

Summary

FDA records drug Class II recall D-0499-2020, published November 27, 2019 and initiated November 8, 2019. Recalling firm: Washington Homeopathic Products, Inc.; Status: Terminated; Reported quantity: 487 bottles; Lot: Lot #: BR18C283. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products were not manufactured under current good manufacturing practices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Washington Homeopathic Products, Inc.
Distributor
Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Lot
Lot #: BR18C283
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Magnesia Phosphorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64197 2. recalled?

Yes. FDA published recall D-0499-2020 on November 27, 2019. Reported hazard: CGMP Deviations: products were not manufactured under current good manufacturing practices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter